USA: +1 347 690-0211 | UK: +44 2032 894158 | JAPAN: +81 50 5806 9039 | Translate : 

report img

Pharmacovigilance and Drug Safety Software Market By Functionality (ADR Reporting, Drug Safety Audits, Issue Tracking, & Fully Integrated Software), By Delivery Mode (On-Premise & On-Demand), By End-User (Pharma & Biotech Companies, CROs, BPOs, & Others), And By Regions - Global & Regional Industry Perspective, Comprehensive Analysis, and Forecast 2021 – 2026

Covid-19

Global Pharmacovigilance and Drug Safety Software Market Size, Share

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Insights

[187+ Pages Report] According to the latest report titled “Global Pharmacovigilance and Drug Safety Software Market” published by Facts & Factors, the study offers a detailed and comprehensive read. The global pharmacovigilance and drug safety software market witnessed a significant market value of USD 160.2 Million in the year 2020 with a CAGR value of 5.9% to a projected value of USD 205.9 Million in the year 2026.

logoMarket Overview

Pharmacovigilance or drug safety is the definition of a branch of science that deals with the detection, monitoring, assessing, and prevention of harmful effects of the intended pharmaceutical drugs. These software tools mainly help with creating, classifying, and reviewing pharmacovigilance data which helps in creating insights and awareness among the healthcare professionals. Pharmacovigilance software tools are basically used in adverse event reporting software, drug safety audits software, issue tracking software, and fully integrated software measures.

logoIndustry Growth Factors

The primary driving forces behind the significant growth during the advent of the forecast period attributes to the rising incidences of adverse drug reactions (ADRs) coupled with increasing adoption of pharmacovigilance software associated with outsourcing the latter into CROs and biotech companies to name a few. Additionally, increased scrutinized measures for prior and post commercialization of drugs coupled with rising complexity related to drug testing measures are expected to increase the footprint of the global pharmacovigilance and drug safety software market during the advent of the forecast period. Moreover, new service launches, agreements, and partnerships coupled with intense software developments coupled with expansive attitude of the key market players will boost the growth of the global pharmacovigilance and drug safety software market during the advent of the forecast period.

The global pharmacovigilance and drug safety software market is driven by rising penetration of the latter tools due to increasing internet connectivity coupled with the rising globalization to name a few. Growing health information functionalities coupled with a shifting trend of manufacturers toward increasing PV and drug safety software will fuel the growth of the global pharmacovigilance and drug safety software market during the advent of the forecast period. However, a lack of a skilled workforce among the pharmacovigilance professionals is expected to decrease the growth of the global pharmacovigilance and drug safety software market during the advent of the forecast period.

Pharmacovigilance and Drug Safety Software Market

logoSegmentation Analysis

The global pharmacovigilance and drug safety software market is segmented into functionality, delivery mode, end-user, and regions.

Based on functionality, the global pharmacovigilance and drug safety software market is classified into ADR reporting, drug safety audits, issue tracking, and fully integrated software. The ADR reporting segment is expected to witness the largest market share during the advent of the forecast owing to data entry & management tools with minimum errors coupled with introduction of advanced data integration solutions to name a few. Based on delivery mode, the global pharmacovigilance and drug safety software market is classified into on-premise and on-demand. The on-premise solutions segment is expected to occupy the largest market share during the advent of the forecast period owing to rising adoption of the latter by large pharmaceutical companies coupled with increased accessibility in the form of remote locations to name a few. The global pharmacovigilance and drug safety software market is fragmented into pharma & biotech companies, CROs, BPOs, and others on the basis of end-user. The segment pertaining to pharma & biotech companies is expected to witness the largest market share during the advent of the forecast period owing to the latter’s ability in facilitating clinical trial programs in order to reduce the burden on medical expenditure coupled with minimizing operational expenses to name a few.

logo Report Scope

Report Attribute

Details

Market Size in 2020

USD 160.2 Million

Projected Market Size in 2026

USD 205.9 Billion

CAGR Growth Rate

5.9% CAGR

Base Year

2020

Forecast Years

2021-2026

Key Market Players

Wipro, TCS, Cognizant, Oracle Corporation, ArisGlobal, AB Cube, Max Delivery, Relsys, Sparta Systems, Inc., and Others

Key Segment

Functionality, Delivery Mode, End-Users, and Region

Major Regions Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Purchase Options

Request customized purchase options to meet your research needs. Explore purchase options

logo Regional Analysis

North America is expected to witness the largest market share during the advent of the forecast period owing to the rising number of government-aided initiatives in favoring adoption of PV software systems coupled with rising surveillance measures for providing relevant data in less time to name a few. Asia-Pacific is expected to witness the fastest growing CAGR during the advent of the forecast period owing to the rise in research outsourcing by pharmaceutical giants coupled with growing public and private investments to name a few. Moreover, the rising number of clinical trials in the region coupled with an increasing number of public safety announcements and initiatives taken by the local and regional government bodies will increase the footprint of the pharmacovigilance and drug safety software market during the advent of the forecast period.

logo Competitive Players

The key market participants for the global pharmacovigilance and drug safety software market are Wipro, TCS, Cognizant, Oracle Corporation, ArisGlobal, AB Cube, Max Delivery, Relsys, Sparta Systems, Inc., United BioSource Corporation, EXTEDO GmbH, Ennov Solutions, Inc., Online Business Applications, Inc., Sarjen Systems Pvt. Ltd., and Umbra Global, among others.

logo By Functionality Segment Analysis

  • ADR Reporting
  • Drug Safety Audits
  • Issue Tracking
  • Fully Integrated Software

logo By Delivery Mode Segment Analysis

  • On-Premise
  • On-Demand

logo By End-User Segment Analysis

  • Pharma & Biotech Companies
  • CROs
  • BPOs
  • Others

logo By Regional Segment Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of MEA

Covid-19

Pharmacovigilance and Drug Safety Software Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Major Market Players

  • Wipro
  • TCS
  • Cognizant
  • Oracle Corporation
  • ArisGlobal
  • AB Cube
  • Max Delivery
  • Relsys
  • Sparta Systems Inc.
  • United BioSource Corporation
  • EXTEDO GmbH
  • Ennov Solutions Inc.
  • Online Business Applications Inc.
  • Sarjen Systems Pvt. Ltd.
  • Umbra Global
     

Frequently Asked Questions

The governing factors for the global pharmacovigilance and drug safety software market can be credited to rising incidences of adverse drug reactions (ADRs) coupled with increasing adoption of pharmacovigilance software associated with outsourcing the latter for CROs and biotech companies to name a few
According to Facts & Factors, the global pharmacovigilance and drug safety software market is expected to generate revenue of around USD 205.9 Million by end of 2026, growing at a CAGR of around 5.9% between 2021 and 2026.
North America is expected to witness the largest market share during the advent of the forecast owing to rising number of government-aided initiatives for favoring an adoption of PV software systems coupled with rising surveillance measure for providing relevant data in less time to name a few.
The key market participants for the global pharmacovigilance and drug safety software market are Wipro, TCS, Cognizant, Oracle Corporation, ArisGlobal AB Cube, Max Delivery, Relsys, Sparta Systems, Inc., United BioSource Corporation, EXTEDO GmbH, and Ennov Solutions, Inc., among others.
why choose fnf
key questions answers

Related Reports

report img

Oral Anticoagulants Market Report 2022 – 2028

[236+ Pages Report] According to the report published by Facts Factors, the global oral anticoagulants market size was worth around USD 18 billion in 2021 and is predicted to grow to around USD 34.1 billion by 2028 with a compound annual growth rate (CAGR) of roughly 9.6% between 2022 and 2028. Th...

Published Date : 23-Sep-2022 | | Category : | Pages : 236 | Format : Read more

Inquiry for Buying Request Sample
report img

Oral Anticoagulants Market Report 2022 – 2028

[236+ Pages Report] According to the report published by Facts Factors, the global oral anticoagulants market size was worth around USD 18 billion in 2021 and is predicted to grow to around USD 34.1 billion by 2028 with a compound annual growth rate (CAGR) of roughly 9.6% between 2022 and 2028. Th...

Published Date : 23-Sep-2022 | | Category : | Pages : 236 | Format : Read more

Inquiry for Buying Request Sample